This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Looking to expand your small business? Discover various ways to explore new opportunities and drive growth effectively.
20,508 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Bitcoin holders are feeling the bite as higher gas bills and elevated mortgage costs reshape household budgets and cr...
Bitcoin is notoriously volatile, but history shows recurring recovery patterns after big crashes. This article explai...
Northcoast downgraded Norwegian Cruise Line amid macro headwinds, signaling tougher times for the sector as Middle Ea...
A high-stakes rehearsal moment sparked a broader look at how money, contracts, and workplace culture intersect in the...
DeFi endured its worst April in over a year, with hundreds of millions lost to hacks. The sector now faces a shift to...
A majority of parents are now including teens in financial talks with advisors, signaling a broader move toward famil...
ShoreHaven Wealth Partners is shifting focus from a U.S.-centric mix to international exposure via an active rotation...
A shifting housing supply could change how loans are priced and approved. This article breaks down what oversupply me...
Andrej Karpathy, a founding member of OpenAI, has moved to Anthropic, marking a pivotal leadership shift in the AI ra...
Greg Abel is guiding Berkshire Hathaway into a strategic cleanup phase. Discover the two key exits reportedly tied to...
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...